Left Ventricular Wall Stress-Mass-Heart Rate Product and Cardiovascular Events in Treated Hypertensive Patients: LIFE Study (Q41291894)

29 September 2017

title

Left Ventricular Wall Stress-Mass-Heart Rate Product and Cardiovascular Events in Treated Hypertensive Patients: LIFE Study (English)

1 reference

29 September 2017

author

Vasilios Papademetriou

1 reference

29 September 2017

Björn Dahlöf

0 references

Richard B Devereux

object named as

Richard B Devereux

1 reference

ORCID Public Data File 2021

29 September 2017

Kurt Boman

1 reference

author name string

Casper N Bang

1 reference

29 September 2017

Mary J Roman

1 reference

29 September 2017

Vittorio Palmieri

1 reference

29 September 2017

Eva Gerdts

1 reference

29 September 2017

Markku S Nieminen

1 reference

29 September 2017

Kristian Wachtell

1 reference

29 September 2017

Darcy A Hille

1 reference

29 September 2017

language of work or name

English

0 references

publication date

21 September 2015

1 reference

29 September 2017

1 reference

29 September 2017

1 reference

29 September 2017

1 reference

29 September 2017

page(s)

945-953

1 reference

Persistence of left ventricular hypertrophy is associated with increased cardiovascular morbidity and mortality in hypertensive patients with lower achieved systolic pressure during antihypertensive treatment

29 September 2017

cites work

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1161/HYPERTENSIONAHA.114.05582

Echocardiographic left ventricular geometry in hypertensive patients with electrocardiographic left ventricular hypertrophy: The LIFE Study

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1161/HYPERTENSIONAHA.114.05582

Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings.

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1161/HYPERTENSIONAHA.114.05582

Electrocardiographic detection of left ventricular hypertrophy by the simple QRS voltage-duration product

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1161/HYPERTENSIONAHA.114.05582

Left ventricular wall stresses and wall stress-mass-heart rate products in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint reduction in hypertension

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1161/HYPERTENSIONAHA.114.05582

Relation of Left Ventricular Mass and Geometry to Morbidity and Mortality in Uncomplicated Essential Hypertension

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1161/HYPERTENSIONAHA.114.05582

The relative effects of left ventricular hypertrophy, coronary artery disease, and ventricular dysfunction on survival among black adults

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1161/HYPERTENSIONAHA.114.05582

Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1161/HYPERTENSIONAHA.114.05582

Universal definition of myocardial infarction

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1161/HYPERTENSIONAHA.114.05582

Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1161/HYPERTENSIONAHA.114.05582

Prognostic value of left ventricular mass in uncomplicated acute myocardial infarction and one-vessel coronary artery disease

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1161/HYPERTENSIONAHA.114.05582

Relation of arterial structure and function to left ventricular geometric patterns in hypertensive adults

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1161/HYPERTENSIONAHA.114.05582

Hemodynamic determinants of oxygen consumption of the heart with special reference to the tension-time index.

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1161/HYPERTENSIONAHA.114.05582

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1161/HYPERTENSIONAHA.114.05582

Population impact of losartan use on stroke in the European Union (EU): projections from the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1161/HYPERTENSIONAHA.114.05582

Association of carotid atherosclerosis and left ventricular hypertrophy.

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1161/HYPERTENSIONAHA.114.05582

Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1161/HYPERTENSIONAHA.114.05582

Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: The Losartan Intervention for Endpoint reduction in Hypertension (LIFE) Study

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1161/HYPERTENSIONAHA.114.05582

Left Ventricular Mass and Risk of Stroke in an Elderly Cohort

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1161/HYPERTENSIONAHA.114.05582

Prediction of Mortality Risk by Different Methods of Indexation for Left Ventricular Mass

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1161/HYPERTENSIONAHA.114.05582

Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1161/HYPERTENSIONAHA.114.05582

Electrocardiographic identification of increased left ventricular mass by simple voltage-duration products

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1161/HYPERTENSIONAHA.114.05582

Role of preclinical cardiovascular disease in the evolution from risk factor exposure to development of morbid events

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1161/HYPERTENSIONAHA.114.05582

Prognostic significance of left ventricular mass change during treatment of hypertension

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1161/HYPERTENSIONAHA.114.05582

Comparison of classification of the severity of hypertension by blood pressure level and by World Health Organization criteria in the prediction of concurrent cardiac abnormalities and subsequent complications in essential hypertension

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1161/HYPERTENSIONAHA.114.05582

Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/references/10.1161/HYPERTENSIONAHA.114.05582

Identifiers

DOI

10.1161/HYPERTENSIONAHA.114.05582

1 reference

29 September 2017

1 reference